About this trial
The study is of high importance to Veterans' health because it will study a suicide prevention intervention in a Veteran population that is at high risk of suicide but has not been a specific focus of the Veteran Affairs' (VA's) suicide prevention efforts. Specifically, a growing number of Veterans are now receiving acute mental health treatment in VA-purchased settings (commonly referred to as Community Care). While these Veterans are at high risk of suicide after discharge, very little is known about how to prevent suicide in these Veterans. This study will directly address this problem by looking at whether a promising suicide prevention strategy called the VA Brief Intervention and Contact Program (VA BIC) can decrease the risk of suicide in Veterans after they are discharged from a non-VA mental health treatment setting. The proposed research is highly pertinent to the VA's top clinical priority-to prevent suicide in Veterans.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Veteran who is eligible to receive VA services
Able to speak English
Received acute psychiatric treatment in a non-VA setting affiliated with VA in Northern New England
Endorse recent suicidal ideation (score 2+ on Beck Scale for Suicidal Ideation)
Disqualifiers
Unable to provide informed consent
Currently receiving assertive community treatment
Potentially vulnerable populations including prisoners, institutionalized patients, or patients currently admitted on involuntary commitment status
Study physician deems the patient is not clinically appropriate because of clinical status such as presence of active psychosis or dementia
Trial design
Parallel
Treatments tested in this trial
VA BIC
BehavioralVA BIC is a suicide prevention strategy that is designed to meet the needs of Veterans who receive acute psychiatric treatment. VA BIC can be delivered by a trained mental health provider (e.g., mental health nurse, social worker, psychologist, psychiatrist). VA BIC includes two synergistic elements to support the patient after a mental health discharge. The elements include a brief educational session, where the patient receives a one-on-one, one-hour, personalized educational session on suicide prevention. The session incorporates aspects of motivational interviewing. The patient then receives 7 regular follow-up contacts that are conducted by the interventionist. Here the interventionist monitors symptoms, assesses treatment adherence, reviews the safety plan, and assists the patient with engaging in steps to promote their well-being. The sessions incorporate aspects of motivational interviewing. Of note patients in this arm will also receive standard care.
Standard Care
Other interventionRegardless of study assignment, all patients will have access to standard care provided upon mental health discharge in non-VA settings. VA staff will also follow standard procedures for mitigating risk including placing Veterans on high risk list when clinically appropriate.
Treatment groups
Trial outcomes
Primary outcomes
Suicidal Ideation: The Beck Scale for Suicidal Ideation (BSS)
The Beck Scale for Suicidal Ideation (BSS) is a self-reported, 21-item scale that assesses symptoms of suicidal ideation. The total score ranges from 0-38. While there is no established BSS cutoff score to classify suicide risk, there is evidence that higher scores on the BSS correspond to more severe suicidal ideation and that a change of five points or more on the total BSS scores may be clinically relevant.
Secondary outcomes
Mental Healthcare Utilization: The number of mental health visits attended
The investigators will measure the total number of mental health visits that patients attended. The investigators will abstract these data from the electronic medical record. Because some patients may attend mental health visits outside of the VA healthcare system, the investigators will use a standardized data collection form to ask patients to self-report on any non-VA mental health visits they attended.
Patient perception of ability to cope with suicidal behavior: The Suicide-Related Coping Scale (SRCS)
The Suicide-Related Coping Scale (SRCS) is a self-reported, 17-item scale that assesses a patient's perception of their ability to manage suicidal behavior. The scale includes two-subscales including an External Coping subscale (7-items) and an Internal Coping subscale (7-items). The total scores on the SRCS range from 0-68. The total scores on the subscales range from 0-28 for the External Coping subscale and 0-28 for the Internal Coping subscale. Higher scores indicate greater belief in ability to cope with suicidal behavior.
Social Connectedness: Interpersonal Needs Questionnaire-15 (INQ-15)
The Interpersonal Needs Questionnaire-15 (INQ-15) is a self-reported, 15-item scale that assesses a patient's perception of their connectedness with others. The total scores range from 15- 105. The scale includes two-subscales: a Thwarted Belongingness subscale (9-items) and a Perceived Burdensomeness subscale (6-items) that are used to assess different aspects of connectedness. The total scores on the Thwarted Belongingness subscale range from 9-63. The total scores on the Perceived Burdensomeness subscale range from 6-42. Higher scores indicate worse perceived connectedness.
Suicide Attempt Events: Fatal and non-Fatal Suicide Attempts
The investigators will measure the number of fatal and non-fatal suicide attempts. The investigators will report the number of patients who experience at least one suicide attempt (fatal and non-fatal). To assess for suicide attempts (fatal/non-fatal), the investigators will use the subpart of the Columbia Suicide Severity Rating Questionnaire (C-SSRS). This is a valid measure of suicidal behavior. The investigators will also review the medical record for reports of suicide attempts (fatal/non-fatal). Of note the subpart of the C-SSRS that assesses for suicidal behavior including suicide attempts does not generate a score. It only reports on the occurrence of the event.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
VA Office of Research and Development
Lead sponsor
White River Junction Veterans Affairs Medical Center
Collaborator